InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43
United States Fiscal year ends December CIK 0001817713 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

31
Insider
Date
Role
Action
Shares
Price
Amount
Andrew Hollman Meyer
1 Dec 2025
Chief Business Officer
Sold after exercise
633
$33.52
$21.22K
Andrew Hollman Meyer
1 Dec 2025
Chief Business Officer
Sold after exercise
2,700
$32.85
$88.71K
Andrew Hollman Meyer
14 Nov 2025
Chief Business Officer
Sold after exercise
3,333
$30.00
$99.99K
Andrew Hollman Meyer
28 Oct 2025
Chief Business Officer
Sold after exercise
16,665
$30.06
$500.99K
Andrew Hollman Meyer
1 May 2025
Chief Business Officer
Sold after exercise
400
$32.60
$13.04K
Andrew Hollman Meyer
1 May 2025
Chief Business Officer
Sold after exercise
2,933
$31.95
$93.70K
Andrew Hollman Meyer
21 Apr 2025
Chief Business Officer
Sold after exercise
3,334
$30.00
$100.02K
Andrew Hollman Meyer
3 Mar 2025
Chief Business Officer
Sold after exercise
901
$32.85
$29.60K
Andrew Hollman Meyer
3 Mar 2025
Chief Business Officer
Sold after exercise
2,433
$31.88
$77.58K
Andrew Hollman Meyer
3 Feb 2025
Chief Business Officer
Sold after exercise
100
$43.60
$4.36K
Andrew Hollman Meyer
3 Feb 2025
Chief Business Officer
Sold after exercise
816
$42.77
$34.90K
Andrew Hollman Meyer
3 Feb 2025
Chief Business Officer
Sold after exercise
2,418
$42.08
$101.74K
Avalon Ventures XI, L.P.
17 Oct 2024
10% owner
Sold after exercise
1,843
$50.02
$92.19K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
10,957
$50.80
$556.62K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
30,094
$50.61
$1.52M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
5,710
$50.61
$288.98K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
29,474
$50.61
$1.49M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
61,445
$49.69
$3.05M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
11,657
$49.69
$579.24K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
60,179
$49.69
$2.99M
Avalon Ventures XI, L.P.
30 Sep 2024
10% owner
Sold after exercise
958
$46.24
$44.30K
Andrew Hollman Meyer
27 Sep 2024
Chief Business Officer
Sold after exercise
50,000
$45.96
$2.30M
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
1,826
$46.19
$84.34K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
1,542
$47.74
$73.62K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
293
$47.74
$13.99K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
1,511
$47.74
$72.14K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
46,861
$46.42
$2.18M
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
8,894
$46.42
$412.86K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
45,894
$46.42
$2.13M
Jay Lichter
13 Sep 2024
10% owner
Sold after exercise
3,815
$46.68
$178.08K
Avalon Ventures XI, L.P.
9 Sep 2024
10% owner
Sold after exercise
2,182
$42.33
$92.36K
Show all 125 transactions →

What was left out

Form 4 filings counted 136
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 31
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 36,004,274
Sales filed before the plan box existed 12
History held since 14 Jun 2021